Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Operating Leases: 2024-2025

Historic Operating Leases for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $8.4 million.

  • Kura Oncology's Operating Leases rose 53.02% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 53.02%. This contributed to the annual value of $5.2 million for FY2024, which is N/A change from last year.
  • Kura Oncology's Operating Leases amounted to $8.4 million in Q3 2025, which was up 2.55% from $8.2 million recorded in Q2 2025.
  • Kura Oncology's 5-year Operating Leases high stood at $8.4 million for Q3 2025, and its period low was $5.2 million during Q4 2024.